Myelodysplastic syndromes trials in Spain
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1RecruitingResearch participation
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Madrid, Pamplona
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00EU 2026-525234-39-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Salamanca, Valencia
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285EU 2024-516009-22-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Salamanca, Sevilla, Valencia
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480EU 2025-523544-12-00Registry updated 2026-11-06
Phase 1/2RecruitingResearch participation
A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 16
- Run by
- Cellcentric Limited
See details and how to join2024-519498-20-00EU 2024-519498-20-00Registry updated 2026-11-05
Phase 1Enrolling by invitationTrial-stage medicine
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Barcelona, Madrid, Pamplona, Salamanca
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509EU 2024-515457-21-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Where
- Barcelona, Madrid, Valencia
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- Genmab
See details and how to joinNCT07384715EU 2025-523101-15-00Registry updated 2026-11-04
Phase 1Not yet recruitingResearch participation
Bioavailability and Bioequivalence Study of Ziftomenib in Participants with Relapsed/Refractory AML or MDS
- Where
- Barcelona, Madrid, Oviedo, Sevilla, Valencia
- Age
- 18 years and over
- People
- 107 worldwide
- Run by
- Kura Oncology Inc.
See details and how to join2025-524332-19-00EU 2025-524332-19-00Registry updated 2026-10-28
Phase 1RecruitingTrial-stage medicine
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
- Where
- Cáceres, Valencia
- Age
- 18 years and over
- People
- 105 worldwide
- Run by
- Stelexis BioSciences
See details and how to joinNCT06533761EU 2024-518071-58-00Registry updated 2026-10-20
Phase 2RecruitingTrial-stage medicine
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Where
- Barcelona, L'Hospitalet de Llobregat, Oviedo, Salamanca, Valencia
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Takeda
See details and how to joinNCT04419649EU 2023-507469-24-00Registry updated 2026-10-19
Phase 2RecruitingTrial-stage medicine
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
- Where
- Barcelona, L'Hospitalet de Llobregat, Salamanca
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Swedish Orphan Biovitrum
See details and how to joinNCT06782373EU 2024-516347-41-00Registry updated 2026-10-16
Phase 3RecruitingTrial-stage medicine
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Badalona, Barcelona, Cáceres, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona, Salamanca, Sevilla, Valencia
- Age
- 18 years and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414EU 2024-517247-31-00Registry updated 2026-10-13
Phase 1/2RecruitingResearch participation
Multi-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS
- Where
- Barcelona, Cáceres, Madrid, Oviedo, Pamplona, Valencia
- Age
- 18 years and over
- People
- 60
- Run by
- Aop Orphan Pharmaceuticals GmbH
See details and how to join2025-523396-38-00EU 2025-523396-38-00Registry updated 2026-10-09
Phase 2/3RecruitingTrial-stage medicine
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Badalona, Barcelona, Cáceres, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo, Pamplona, Salamanca, Valencia
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317EU 2024-515098-93-00Registry updated 2026-10-06
Phase 2Enrolling by invitationTrial-stage medicine
RVU120 Rollover Study
- Where
- Pamplona
- Age
- 18 years and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058EU 2025-521673-14-00Registry updated 2026-09-17
Phase 2RecruitingTrial-stage medicine
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875EU 2024-511407-42-00Registry updated 2026-09-15
Phase 1/2RecruitingTrial-stage medicine
A Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Barcelona, Salamanca, Sevilla, Valencia
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130EU 2023-508881-14-00Registry updated 2026-09-14
Phase 3RecruitingTrial-stage medicine
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Badalona, Barcelona, Madrid, Pamplona, Salamanca, Sevilla, Valencia
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953EU 2023-510155-37-00Registry updated 2026-09-03
Phase 2Enrolling by invitationTrial-stage medicine
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Barcelona, Lleida, Logroño, Madrid, Murcia
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570EU 2024-516293-29-01Registry updated 2026-07-28
Phase 1/2Not yet recruitingTrial-stage medicine
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348EU 2025-525128-88-00Registry updated 2026-07-22
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060Registry updated 2026-07-01
Phase 1/2RecruitingTrial-stage medicine
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Badalona, Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597Registry updated 2026-06-24
Phase 2RecruitingTrial-stage medicine
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Pamplona, Salamanca, Valencia
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06847867EU 2024-519928-24-00Registry updated 2026-06-02
Phase 1RecruitingTrial-stage medicine
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Age
- 18 years and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897EU 2024-516291-16-00Registry updated 2026-05-28
Phase 1RecruitingTrial-stage medicine
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910EU 2024-516292-33-00Registry updated 2026-05-28
Phase 1/2RecruitingTrial-stage medicine
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander, Santiago de Compostela, Valencia
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555Registry updated 2026-03-24
All Myelodysplastic syndromes trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.